Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019
Peter D Burbelo, Francis X Riedo, Chihiro Morishima, Stephen Rawlings, Davey Smith, Sanchita Das, Jeffrey R Strich, Daniel S Chertow, Richard T Davey, Jeffrey I Cohen, Peter D Burbelo, Francis X Riedo, Chihiro Morishima, Stephen Rawlings, Davey Smith, Sanchita Das, Jeffrey R Strich, Daniel S Chertow, Richard T Davey, Jeffrey I Cohen
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is associated with respiratory-related disease and death. Assays to detect virus-specific antibodies are important to understand the prevalence of infection and the course of the immune response.
Methods: Quantitative measurements of plasma or serum antibodies to the nucleocapsid and spike proteins were analyzed using luciferase immunoprecipitation system assays in 100 cross-sectional or longitudinal samples from patients with SARS-CoV-2 infection. A subset of samples was tested both with and without heat inactivation.
Results: At >14 days after symptom onset, antibodies against SARS-CoV-2 nucleocapsid protein showed 100% sensitivity and 100% specificity, whereas antibodies to spike protein were detected with 91% sensitivity and 100% specificity. Neither antibody levels nor the rate of seropositivity were significantly reduced by heat inactivation of samples. Analysis of daily samples from 6 patients with COVID-19 showed anti-nucleocapsid and spike protein antibodies appearing between days 8 and 14 after initial symptoms. Immunocompromised patients generally had a delayed antibody response to SARS-CoV-2, compared with immunocompetent patients.
Conclusions: Antibody to the nucleocapsid protein of SARS-CoV-2 is more sensitive than spike protein antibody for detecting early infection. Analyzing heat-inactivated samples with a luciferase immunoprecipitation system assay is a safe and sensitive method for detecting SARS-CoV-2 antibodies.
Keywords: COVID-19; SARS-CoV-2; coronavirus; serology.
Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Figures
References
- Chan JF, Yuan S, Kok KH et al. . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395:514–23.
- Wu F, Zhao S, Yu B, et al. . A new coronavirus associated with human respiratory disease in China. Nature 2020; 579:265–9.
- Zhou P, Yang XL, Wang XG, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–3.
- Chen L, Liu W, Zhang Q et al. . RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 2020; 9:313–19.
- Chen N, Zhou M, Dong X et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507–13.
- Huang C, Wang Y, Li X et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.
- Zhu N, Zhang D, Wang W et al. . A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–33.
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17:181–92.
- Holshue ML, DeBolt C, Lindquist S et al. . First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382:929–36.
- Zou L, Ruan F, Huang M, et al. . SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177–9.
- To KK, Tsang OT, Leung WS, et al. . Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20:565–74.
- Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev 2020. doi: 10.1016/j.tmrv.2020.02.003.
- Chen W, Lan Y, Yuan X, et al. . Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect 2020; 9: 469–73.
- Leung DT, Tam FC, Ma CH, et al. . Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 2004; 190:379–86.
- Zhu H, Hu S, Jona G, et al. . Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc Natl Acad Sci U S A 2006; 103:4011–6.
- Guo L, Ren L, Yang S et al. . Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis 2020:ciaa310. doi: 10.1093/cid/ciaa310.
- Zhao J, Yuan Q, Wang H et al. . Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020:ciaa344. doi: 10.1093/cid/ciaa344.
- Wolfel R, Corman VM, Guggemos W et al. . Virological assessment of hospitalized patients with COVID-2019. Nature 2020. doi: 10.1038/s41586-020-2196-x.
- Li Z, Yi Y, Luo X et al. . Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020:10.1002/jmv.25727. doi: 10.1002/jmv.25727.
- Burbelo PD, Lebovitz EE, Notkins AL. Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases. Transl Res 2015; 165:325–35.
- Alagaili AN, Briese T, Mishra N, et al. . Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 2014; 5:e00884–14.
- Zhou P, Fan H, Lan T, et al. . Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 2018; 556:255–8.
- Yunoki M, Urayama T, Yamamoto I, Abe S, Ikuta K. Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. Vox Sang 2004; 87:302–3.
- Leclercq I, Batéjat C, Burguière AM, Manuguerra JC. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respir Viruses 2014; 8:585–6.
- Burbelo PD, Ching KH, Klimavicz CM, Iadarola MJ. Antibody profiling by luciferase immunoprecipitation systems (LIPS). J Vis Exp 2009:1549.
- Burbelo PD, Ferré EMN, Chaturvedi A, et al. . Profiling autoantibodies against salivary proteins in sicca conditions. J Dent Res 2019; 98:772–8.
- Wrapp D, Wang N, Corbett KS, et al. . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367:1260–3.
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536–44.
- Al-Muzairai IA, Mansour M, Almajed L, Alkanderi N, Alshatti N, Samhan M. Heat inactivation can differentiate between IgG and IgM antibodies in the pretransplant cross match. Transplant Proc 2008; 40:2198–9.
- Chen T, Wu D, Chen H et al. . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368:m1091.
- Chen G, Wu D, Guo W et al. . Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest 2020; 130:2620–9.
- Guo T, Fan Y, Chen M et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020:e201017. doi: 10.1001/jamacardio.2020.1017.
- Wang W, Xu Y, Gao R et al. . Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020; 323:1843–4.
- Darnell ME, Taylor DR. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion 2006; 46: 1770–7.
- Brenier-Pinchart MP, Fricker-Hidalgo H, Dard C, Pelloux H. Impact of heat-inactivation on anti-Toxoplasma IgM antibody levels. Clin Chem Lab Med 2017; 55: e291–3.
Source: PubMed